RP-HPLC-PDA method for the simultaneous determination of Phenylepherine, Chlorpheneramine, Paracetamol and Dextromethorphan in bulk and marketed formulation
Journal: Journal of Pharmacy Research (Vol.11, No. 4)Publication Date: 2017-04-05
Authors : Meruva Sathish Kumar; P.Shanmugapandiyan;
Page : 306-312
Keywords : Phenylephrine; Chlorpheneramine; Paracetamol; Dextromethorphan; Reverse phase HPLC; PDA Detector;
Abstract
Objective: a new method has been developed for simultaneous estimation of phenylephrine, chlorpheneramine, paracetamol and dextromethorphan in bulk and marketed formulations. Method: Chromatography was performed using C8 column of dimension 250*4.6mm and particle size 5µ. the best results were obtained by phosphate buffer (20 Mm) pH 6.6 adjusted with diluted orthophosphoric acid and Acetonitrile(70:30) taken in Gradient Programme at flow rate of 1ml/m with detection at 225 nm. Retention time was less than 6mins for all the four drugs. According to ICH guidelines the method was proven to be linear, precise and accurate. Results: The linearity ranges from 0.5-487.5 µg/ml. LOQ was found to be 0.02,0.01,3.92 and 0.06. The sample solution injected after 24 hr did not show any appreciable change. Recovery was found to be 100.38-100.53. Conclusion: The developed method was simple, specific and sensitive as the excipients have no interference in the determination of main components. The proposed method can be used for routine analysis of phenylephrine, chlorpheneramine, paracetamol and dextromethorphan in combined dosage form which are present in variable concentrations.
Other Latest Articles
- Aqueous Curry leaves extract protects against lead induced oxidative stress in rat spleen: a new insight
- A Review on Diabetic Retinopathy Prevention and Management in Community care
- CORPORATE CULTURE HEALTH AS A CRUCIAL SUCCESS FACTOR IN MANAGING A COMPANY
- EVALUATION OF THE STATE OF THE HUMAN CAPITAL OF THE ORGANIZATION
Last modified: 2017-05-05 23:21:32